How Intestinal Permeability Changes With Age
Intestinal permeability is the regulated passage of solutes across the gut epithelium. This page summarises research models — cellular, murine and human — that examine how barrier function is measured and modified, and w
Intestinal permeability is the regulated, size-selective passage of solutes across the intestinal epithelium, mediated by the paracellular route (tight junctions between enterocytes) and the transcellular route. It is not a disease and not a diagnosis; it is a measurable physiological parameter. In the research literature it is quantified most often as the urinary lactulose:mannitol ratio (LMR) after an oral sugar load, or in animal work by FITC-dextran flux and transepithelial electrical resistance (TEER) across cultured monolayers. The evidence summarised here does not supply a molecular formula, sequence or molecular weight for permeability itself, because permeability is a property of a tissue rather than a single compound; where a compound is named below, its identifiers are those given by the source.
The work on this page centres on the tight-junction protein family and the mucosal immune signalling that regulates it — claudins, occludin and zonula occludens proteins — together with the gut microbiota and its metabolites as upstream modulators of barrier integrity.
Research Studies
Marine collagen peptides and barrier repair in Caco-2 and murine colitis models
A low-molecular-weight collagen peptide fraction (LSCP-I, under 3 kDa) derived from the scales of Lutjanus erythropterus was evaluated in Caco-2 cell monolayers exposed to macrophage-mediated inflammatory injury and in murine colitis models. In the cellular model, LSCP-I at 50 µg/mL increased proliferation by 35% and migration by 40%, preserved barrier integrity, reduced reactive oxygen species by 45%, decreased lipid peroxidation by 30%, and restored glutathione and superoxide dismutase levels [1]. These are in vitro and animal findings; no human permeability endpoint was reported in that study.
Oral glutamine and sex-dependent gut responses in diet-induced obesity
Male and female C57BL/6 mice received a standard or high-fat diet (60% kcal from fat) for 14 weeks, with glutamine in drinking water (2 g/kg/day) or no supplementation from week 12. The study was designed to characterise sex differences in metabolic and gut responses to oral glutamine during diet-induced obesity, with intestinal permeability among the measured outcomes [2]. The design itself is the relevant point for this page: barrier outcomes in this model were assessed separately in male and female animals, and the reported responses were not uniform between them.
Zein-based nanoparticles and oral peptide transport in Danio rerio
Hybrid zein-Eudragit RS100-chitosan nanoparticles were developed for oral co-delivery of insulin and liraglutide, addressing enzymatic degradation and poor intestinal permeability as the two principal barriers to oral peptide administration. The particles measured approximately 230 nm with a polydispersity index below 0.1 and a zeta potential of about +46 mV, and structural and thermal analysis indicated a predominantly amorphous, molecularly dispersed payload. Preliminary in vivo evaluation was conducted in Danio rerio [3]. This is a formulation study in a zebrafish model, not a human permeability study.
Exercise and intestinal permeability in elite rowers
An observational study of thirty members of the Polish Youth National Rowing Team, aged 19–24, is designed to evaluate multilevel physiological, molecular, metabolic, intestinal, immunological and psychophysiological responses to rowing-specific exercise, including a 2000-m maximal ergometer test during the competitive phase. Intestinal permeability is one of the integrated adaptive mechanisms under investigation, alongside mitochondrial function, metabolic regulation, immune activation and DNA damage response [4].
Collagen peptide dose-response and aspirin challenge in healthy adults
A clinical trial is evaluating 45 days of daily collagen peptide at three doses (2.5 g, 5 g and 10 g) against placebo in healthy adults, with intestinal permeability measured by the urinary lactulose:mannitol ratio over a 5-hour collection. The primary comparison is change from Day 42 to Day 45 following an acute aspirin (NSAID) challenge [6]. This is the clearest human dose-ranging design in the evidence set for a collagen-derived intervention and a permeability endpoint.
Dietary fibre and permeability in alcohol use disorder
A trial in patients with alcohol use disorder aged 19–65 is testing whether a fibre-enriched diet high in inulin and pectin, combined with standard care, reduces intestinal permeability. The stated hypothesis is that fibre modifies the gut microbiota and its metabolites, thereby decreasing permeability and restoring microbial composition, with further effects on abstinence, craving, anxiety, inflammation, steatosis and hepatic fibrosis [7].
Synbiotic supplementation and subclinical inflammation in overweight adults
A randomised, double-blind, controlled crossover study in twenty healthy overweight participants is testing a sugar-based synbiotic containing inulin and Bacillus coagulans BC30 spores at 1 × 10⁹ CFU/day against a matched control sugar product containing inulin without spores. Participants complete a 2-week run-in and two 4-week intervention periods separated by a 4-week washout. The primary outcome is change in fasting markers of subclinical inflammation, including high-sensitivity C-reactive protein [5].
Akkermansia muciniphila, berberine and barrier integrity in shift workers
A trial in night-shift workers is examining Akkermansia muciniphila and berberine supplementation in relation to insulin sensitivity. The rationale cites circadian misalignment, disrupted sleep and altered eating patterns as drivers of impaired glucose metabolism, with the gut microbiota as a modifying factor; A. muciniphila is described as linked to maintenance of intestinal barrier integrity, and berberine as upregulating the bacterium and improving insulin sensitivity [8].
Permeation enhancers and PROTAC transport in rats
Work on the proteolysis targeting chimera ARV-471 examined how intestinal permeation enhancers affect solubilisation and epithelial transport in rats. The paper notes that PROTAC molecular properties frequently fall outside rule-of-five chemical space, which is associated with poor intestinal solubility, permeability and absorption, and that formulation work has concentrated on solubility rather than intrinsic permeability [9].
NSAID-induced small intestinal injury and barrier protection
A systematic review assessed natural products, functional foods and probiotics for preventing or treating NSAID-induced small intestinal injury, a recognised complication among chronic NSAID and aspirin users for which effective treatment options remain limited. The review considered oxidative stress and microbiome modulation as mechanistic explanations [10]. Related work examined canagliflozin in indomethacin-induced peptic ulcer in relation to inflammation, pyroptosis, autophagy and gut integrity [12].
Permeability in endocrine and metabolic contexts
A review of diagnostic and prognostic biomarkers in polycystic ovary syndrome positions insulin resistance as a central molecular driver of metabolic and reproductive complications, including infertility, obesity and elevated long-term cardiovascular risk [11]. This is included because barrier function is frequently measured alongside insulin sensitivity in metabolic research, not because the review establishes a permeability mechanism.
Comparison of models and endpoints
| Model | Intervention or exposure | Permeability-relevant endpoint |
|---|---|---|
| Caco-2 monolayer (in vitro) | LSCP-I, 50 µg/mL | Barrier integrity, ROS, GSH, SOD [1] |
| Murine colitis | LSCP-I | Barrier protection, redox modulation [1] |
| C57BL/6 mice, high-fat diet | Oral glutamine, 2 g/kg/day | Intestinal permeability, sex-stratified [2] |
| Danio rerio | Zein-Eudragit-chitosan nanoparticles | Oral peptide delivery, preliminary [3] |
| Healthy adults | Collagen peptide 2.5/5/10 g, 45 days | Urinary lactulose:mannitol ratio after aspirin [6] |
| Alcohol use disorder patients | Inulin- and pectin-rich diet | Intestinal permeability [7] |
| Overweight adults | Inulin + B. coagulans BC30 | hs-CRP and subclinical inflammation [5] |
| Night-shift workers | A. muciniphila, berberine | Insulin sensitivity, barrier integrity [8] |
| Rats | Permeation enhancers, ARV-471 | Solubilisation and epithelial transport [9] |
If you are reading this for personal health reasons
The materials described on this page are supplied for laboratory research use only. We do not provide dosing information, medical guidance or recommendations for personal use of any compound. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Marine Collagen Peptide Fraction from Lutjanus erythropterus Scales — https://europepmc.org/article/PMC/PMC13409717
- [2] Opposite metabolic and gut responses to oral glutamine in male and female mice with diet-induced obesity — https://pubmed.ncbi.nlm.nih.gov/42680331/
- [3] Development of zein-based nanoparticles for oral co-delivery of insulin and liraglutide — https://pubmed.ncbi.nlm.nih.gov/42442575/
- [4] Multilevel Exercise Response in Rowers — https://clinicaltrials.gov/study/NCT07613619
- [5] Effects of a Sugar-Based Synbiotic Product on Cardiometabolic and Intestinal Health — https://clinicaltrials.gov/study/NCT07806383
- [6] CP: Intestinal Permeability — https://clinicaltrials.gov/study/NCT07586930
- [7] Administration of Fiber as a Dietary Supplement to Improve the Management of Alcohol Withdrawal — https://clinicaltrials.gov/study/NCT07371286
- [8] Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers — https://clinicaltrials.gov/study/NCT07440147
- [9] Effects of intestinal permeation enhancers on solubilization and epithelial transport of the PROTAC ARV-471 in rats — https://pubmed.ncbi.nlm.nih.gov/42716127/
- [10] Protective Effects of Natural Products, Functional Foods, and Probiotics on NSAID-Induced Small Intestinal Injury — https://pubmed.ncbi.nlm.nih.gov/42510634/
- [11] Diagnostic and prognostic biomarkers in PCOS — https://pubmed.ncbi.nlm.nih.gov/42349674/
- [12] Gastroprotective potential of canagliflozin in indomethacin-induced peptic ulcer — https://pubmed.ncbi.nlm.nih.gov/42235854/